← FDA Drug Approvals (Drugs@FDA)

SIROLIMUS

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS LTD · Approved 2020-10-16

Drug application

FDA Application #

ANDA208691

Application type

Abbreviated New Drug Application (Generic)

Brand name

SIROLIMUS

Generic name

SIROLIMUS

Active ingredients

SIROLIMUS

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

GLENMARK PHARMS LTD

Manufacturer

NORTHSTAR RX LLC

First approval

2020-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown